Stepan Announces Agreement To Acquire North American Polyester Resins Business
NORTHFIELD, Ill., April 30, 2013
NORTHFIELD, Ill., April 30, 2013 /PRNewswire/ --Stepan Company (NYSE: SCL)
today reported that it has reached an agreement with Bayer MaterialScience to
acquire their North American Polyester Resins business, including the
production facility located in Columbus, Georgia. Bayer MaterialScience is a
leading producer of Powder Polyester Resins for metal coatings applications in
NAFTA and Liquid Polyester Resins for CASE (Coatings, Adhesives, Sealants and
Elastomers) applications globally. The facility houses a modern R&D laboratory
for customer technical support and new product development. The 21,000 ton
plant is expandable. The business to be acquired has sales of approximately
$64 million. The definitive agreement is subject to customary closing
conditions and the transaction is projected to close within four to six
weeks. Financial terms of the transaction were not disclosed.
"This acquisition will significantly expand Stepan's polyol product offering.
Stepan is a leading producer of polyester polyol used in rigid insulation
foam. This acquisition will diversify our polyol offering and accelerate our
efforts to grow in CASE and PUSH (Polyurethane Systems House) applications.
The acquisition should be slightly accretive to 2013 earnings," said F. Quinn
Stepan, Jr., President and CEO of Stepan Company. "We intend to make future
capital expenditures to expand the capabilities at the site."
ABOUT STEPAN COMPANY
Stepan Company, headquartered in Northfield, Illinois, is a leading producer
of specialty and intermediate chemicals used in household, industrial,
personal care, agricultural, food and insulation related products. The common
and the convertible preferred stocks are traded on the New York Stock Exchange
under the symbols SCL and SCLPR.
For more information about Stepan Company, please visit the Company online at
Except for historical information, all other information in this news release
consists of forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including among other things,
completion of the proposed transaction with Bayer MaterialScience, These
forward-looking statements are subject to risks and uncertainties that could
cause actual results to differ materially from those projected, anticipated or
implied. The most significant of these uncertainties are described in Stepan
Company's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those
reports, and include (but are not limited to), prospects for our foreign
operations, foreign currency fluctuations, certain global and regional
economic conditions, the probability of future acquisitions and the
uncertainties related to the integration of acquired businesses, the
probability of new products, the loss of one or more key customer or supplier
relationships, the costs and other effects of governmental regulation and
legal and administrative proceedings, including the expenditures necessary to
address and resolve environmental claims and proceedings, and general economic
conditions. As to the proposed transaction, these risks also include
satisfaction of conditions to closing the proposed transaction and achieving
the anticipated benefits of the transaction. These forward-looking statements
are made only as of the date hereof, and Stepan Company undertakes no
obligation to update or revise the forward-looking statements, whether as a
result of new information, future events or otherwise.
SOURCE Stepan Company
Contact: James E. Hurlbutt, (847) 446-7500
Press spacebar to pause and continue. Press esc to stop.